Impact of anaerobic glycolysis and oxidative substrate selection on contractile function and mechanical efficiency during moderate severity ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 3, 2008, Pages

  Zhou, Lufang ^a,d   Huang, Hazel ^b   McElfresh, Tracy A ^b   Prosdocimo, Domenick A ^b   Stanley, William C ^b,c  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angina; Fatty acids; Glucose; Insulin

Indexed keywords

FATTY ACID; IODOACETIC ACID; LACTIC ACID; RADIOISOTOPE; ANTIDIABETIC AGENT; ENZYME INHIBITOR; GLUCOSE; INSULIN;

AEROBIC METABOLISM; ANAEROBIC GLYCOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; EXPERIMENTAL MODEL; FATTY ACID OXIDATION; GLUCOSE OXIDATION; GLYCOLYSIS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; SWINE; ANAEROBIC GROWTH; ANIMAL; BLOOD; BLOOD GAS ANALYSIS; BLOOD PRESSURE; DRUG EFFECT; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANAEROBIOSIS; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CORONARY CIRCULATION; ENZYME INHIBITORS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLYCOLYSIS; HEART RATE; HYPOGLYCEMIC AGENTS; INSULIN; IODOACETATES; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; OXIDATION-REDUCTION; SWINE; VENTRICULAR FUNCTION, LEFT;

EID: 54049117689     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00561.2008     Document Type: Article

References (37)

1. Apstein CS, Deckelbaum L, Hagopian L, Hood WB Jr. Acute cardiac ischemia and reperfusion: contractility, relaxation, and glycolysis. Am J Physiol Heart Circ Physiol 235: H637-H648, 1978.
2. Borst P, Loos JA, Christ EJ, Slater EC. Uncoupling activity of long-chain fatty acids. Biochim Biophys Acta 62: 509-518, 1964.
3. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, Eberli FR. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 101: 2090-2096, 2000.
4. Chandler MP, Chavez PN, McElfresh TA, Huang H, Harmon CS, Stanley WC. Partial inhibition of fatty acid oxidation increases regional contractile power and efficiency during demand-induced ischemia. Cardiovasc Res 59: 143-151, 2003.
5. Chandler MP, Huang H, McElfresh TA, Stanley WC. Increased non-oxidative glycolysis despite continued fatty acid uptake during demandinduced myocardial ischemia. Am J Physiol Heart Circ Physiol 282: H1871-H1878, 2002.
6. Cross HR, Clarke K, Opie LH, Radda GK. Is lactate-induced myocardial ischaemic injury mediated by decreased pH or increased intracellular lactate? J Mol Cell Cardiol 27: 1369-1381, 1995.
7. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 68: 466-481, 1991.
8. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96: 1152-1156, 1997.
9. Ferrannini E, Santoro D, Bonadonna R, Natali A, Parodi O, Camici PG. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol Endocrinol Metab 264: E308-E315, 1993.
10. Hacker TA, Renstrom B, Nellis SH, Liedtke AJ. The role of glucose metabolism in a pig heart model of short-term hibernation. Mol Cell Biochem 180: 75-83, 1998.
11. Jennings RB, Reimer KA, Steenbergen C Jr, Schaper J. Total ischemia III: effect of inhibition of anaerobic glycolysis. J Mol Cell Cardiol 21, Suppl 1: 37-54, 1989.
12. Jeremy RW, Koretsune Y, Marban E, Becker LC. Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ Res 70: 1180-1190, 1992.
13. Liedtke AJ, Nellis SH, Mjos OD. Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts. Am J Physiol Heart Circ Physiol 247: H387-H394, 1984.
14. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 79: 940-948, 1996.
15. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 39: 718-725, 2002.
16. Lopaschuk GD, Wambolt RB, Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264: 135-144, 1993.
17. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293: 437-446, 2005.
18. 2+ homeostasis during beta-adrenergic stimulation. Am J Physiol Heart Circ Physiol 264: H670-H678, 1993.
19. Panchal AR, Comte B, Huang H, Dudar B, Roth B, Chandler M, des RC, Brunengraber H, Stanley WC. Acute hibernation decreases myocardial pyruvate carboxylation and citrate release. Am J Physiol Heart Circ Physiol 281: H1613-H1620, 2001.
20. Panchal AR, Comte B, Huang H, Kerwin T, Darvish A, des Rosiers C, Brunengraber H, Stanley WC. Partitioning of pyruvate between oxidation and anaplerosis in swine hearts. Am J Physiol Heart Circ Physiol 279: H2390-H2398, 2000.
21. Pressman BC, Lardy HA. Effects of surface active agents on the latent ATPase of mitochondria. Biochim Biophys Acta 21: 458-466, 1956.
22. Russell RR 3rd, Yin R, Caplan MJ, Hu X, Ren J, Shulman GI, Sinusas AJ, Young LH. Addictive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo. Circulation 98: 2180-2186, 1998.
23. Salem JE, Cabrera ME, Chandler MP, McElfresh TA, Huang H, Sterk JP, Stanley WC. Step and ramp induction of myocardial ischemia: comparison of in vivo and in silico results. J Physiol Pharmacol 55: 519-536, 2004.
24. Sharma N, Okere IC, Brunengraber DZ, McElfresh TA, King KL, Sterk JP, Huang H, Chandler MP, Stanley WC. Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation. J Physiol 562: 593-603, 2005.
25. Sodi-Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, de Micheli A. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 9: 166-181, 1962.
26. Stanley AW Jr, Moraski RE, Russell RO, Rogers WJ, Mantle JA, Kreisberg RA, McDaniel HG, Rackley CE. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am J Cardiol 36: 929-937, 1975.
27. Stanley WC. Partial fatty acid oxidation inhibitors for stable angina. Expert Opin Investig Drugs 11: 615-629, 2002.
28. Stanley WC, Hernandez LA, Spires D, Bringas J, Wallace S, McCormack JG. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate. J Mol Cell Cardiol 28: 905-914, 1996.
29. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33: 243-257, 1997.
30. Stanley WC, Morgan EE, Huang H, McElfresh TA, Sterk JP, Okere IC, Chandler MP, Cheng J, Dyck JR, Lopaschuk GD. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia. Am J Physiol Heart Circ Physiol 289: H2304-H2309, 2005.
31. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129, 2005.
32. Wang P, Lloyd SG, Chatham JC. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart. Circulation 111: 2066-2072, 2005.
33. Weiss J, Hiltbrand B. Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest 75: 436-447, 1985.
34. Wisneski JA, Stanley WC, Neese RA, Gertz EW. Effects of acute hyperglycemia on myocardial glycolytic activity in humans. J Clin Invest 85: 1648-1656, 1990.
35. Wu L, Belardinelli L, Fraser H. A novel partial fatty acid oxidation inhibitor decreases myocardial oxygen consumption and improves cardiac efficiency in demand-induced ischemic heart. J Cardiovasc Pharmacol 51: 372-379, 2008.
36. Young LH, Renfu Y, Russell R, Hu X, Caplan M, Ren J, Shulman GI, Sinusas AJ. Low flow ischemia leads to translocation of canine heart GLUT4 and GLUT1 glucose transporters to the sarcolemma in vivo. Circulation 95: 415-422, 1997.
37. Zhu P, Lu L, Xu Y, Greyson C, Schwartz GG. Glucose-insulin- potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 278: H595-H603, 2000.